Who We Are?

News Times-HD proudly stands at the forefront of Pakistan’s news websites, offering an unswerving commitment to delivering real-time, pinpoint-accurate coverage across the spectrum of current affairs, business analytics, sports fervor, cutting-edge tech revelations, and groundbreaking health insights. Our exceptional team of seasoned journalists and astute analysts works tirelessly to ensure you are consistently updated with the latest news and global events, sourced from both Pakistan and around the world. Our paramount objective is to keep our readers not only informed but fervently engaged with the ever-evolving world that surrounds them.

Developed By ASK

Tag: Nikkei 225 Index

South Korea’s Kospi, Japan’s Topix hit record highs as investors shrug off Iran tensions

Japan’s Nikkei 225 tops 65,000 for first time as oil falls on Hormuz reopening hopes

Asia-Pacific markets trade higher as investors assess U.S.-Iran peace deal diplomacy

Asia-Pacific markets fall as Trump’s Iran warning stokes fresh oil supply fears

Asia-Pacific markets fall as renewed U.S.-Iran clashes keep investors on edge

Japan’s Nikkei 225 tops 62,000 for the first time as Asia markets look past Trump’s Iran threats

Australia and Japan markets climb, looking past Iran war escalation fears

U.S.-Iran peace talks stall. Here’s where things stand — and what’s next for global markets

Japan’s Nikkei 225 rises to record high as Trump extends Iran ceasefire

Asia markets trade lower as oil surges after U.S. moves to blockade Iran ports

LATEST POSTS

Rick Adelman, Hall of Fame coach who won more than 1,000 games, dies aged 79

Chris Pines low-key romance steps into the spotlight at French Open

Pakistan urges UN to make mediation first line of defence against conflicts amid ME crisis

POPULAR CATEGORY

POPULAR POSTS

Blue state governor roasted as ‘arsonist’ putting out her own fire as she blames outside agitators at ‘siege’

Pakistan, Italy sign agreement to waive visa requirement for diplomatic passport holders

Biotech takeover target Abivax sinks over 30% after bowel disease drug trial update

Who We Are?